The biotech reported Monday morning that they've inked a deal with ... trial unveiled Wednesday at the virtual San Antonio Breast Cancer Symposium.
News
- BioCryst bags $250M in a debt and royalty deal as the executive team preps a new drug launch for ...
- The Latest: Gov. Cuomo bans NYC indoor dining as cases climb
BOSTON — A study published by the journal Science says as many as 300,000 COVID-19 cases around the world can be traced to a two-day biotech ...
- Initial public offerings scheduled to debut next week
Proposed Nasdaq symbol BCAB. Business: Phase 2 biotech developing selective antibody therapies for solid tumors. Dune Acquisition - West Palm ...
- Middle Bit: Iowa Innovation Corporation rebrands to 'BioConnect Iowa'
“Innovation in the biosciences offers a great opportunity for Iowa,” said Paul ... San Antonio, Texas-based financial startup FloatMe has raised a $3.7 ...
- Puma Biotechnology Presents Efficacy and Safety Outcomes from the Phase III NALA Trial at the ...
... with a particular focus on CNS-specific endpoints, at the 2020 Virtual San Antonio Breast Cancer Symposium (SABCS) that is currently taking place.